The stock is down 3%, or $2.81, to $80.26 in premarket trading.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
- Novo Nordisk’s Semaglutide 7.2mg s.c. achieved 21% weight loss in STEP UP trial
- Novo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
- Insulin prices have dropped but some poor patients are paying more, NYT says
- Novo Nordisk Advances Share Repurchase Programme